| Release date: January 2009 Expiration date: January 31, 2010 Estimated time to complete activity: 1.75 hours |
Read through all material and click "BEGIN ACTIVITY" at the bottom of the page. |
- Javascript-enabled browser
- Active Internet connection
- Adobe Acrobat Reader
- Adobe Flash Player plugin v.8.0+
Co-provided by Curatio CME Institute and EduPro Resources LLC
Support for this activity has been provided through an educational grant from Centocor
Activity Overview
Our evolving understanding of the role of new pathways and newly discovered cell populations involved in the pathophysiology of psoriasis offers the potential for novel drug targets and therapeutic agents. A more thorough appreciation of the pathophysiology of psoriasis and the role of certain cell populations and cytokines will help clinicians better understand both the mechanisms of disease and the mechanisms of therapeutic intervention with biologic agents. As novel agents advance in clinical development, clinicians need updates on their mechanisms of action, safety and efficacy profiles, and where they fit into clinical practice.
Target Audience
This activity has been designed to meet the educational needs of dermatologists, dermatology residents and fellows, dermatology nurses, nurse practitioners, physician assistants, and other health care professionals involved in the care of patients with moderate to severe psoriasis.
Learning Objectives
After completing this activity, participants should be able to:
- Define the roles of distinct T-cell populations in the pathophysiology of psoriasis
- Describe mechanisms of therapeutic intervention based on the cellular and molecular pathways
involved in psoriasis - Evaluate clinical safety and efficacy data for new biologic agents for psoriasis
Kenneth B. Gordon, MD—Program Chair View biography
Associate Professor of Dermatology
Northwestern University
Feinberg School of Medicine
Head, Division of Dermatology
Evanston Northwestern Healthcare
Skokie, Illinois
Jeffrey J. Crowley, MD View biography
Bakersfield Dermatology & Skin Cancer Medical Group
Bakersfield, California
Assistant Clinical Professor
Department of Medicine
University of California
Los Angeles, California
Accreditation Statement
Physician:
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Curatio CME Institute designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity.
Nursing:
EduPro Resources LLC is an approved provider of continuing nursing education by New Jersey State Nurses Association (NJSNA), an accredited approver by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation, Provider Number P208-8/08-11.
EduPro is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-14387.
This activity is approved for 1.75 nursing contact hours.
Method of Participation
There are no fees for participating in this continuing education activity. To receive credit during the period January 2009 to January 31, 2010, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.
To obtain a certificate, participants must receive a score of 70% or better on the posttest. The posttest can be accessed at the end of the activity. Please e-mail any questions to cmeinfo@curatiocme.com.
Medium
This activity will be offered as an interactive CD-ROM and posted to the Internet on PsoriasisTx.com. Offering this CME/CNE activity as a CD-ROM and Web posting allows participants to learn on their own time and at their own pace. The interactive nature of the activity allows participants to become engaged and offers visual, written, and spoken education to suit many learning styles.
Disclosure
In accordance with the ACCME’s Standards for Commercial Support and the criteria of the ANCC, all CME and CNE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME/CNE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME/CNE activity content over which the individual has control. Relationship information appears below:
Kenneth B. Gordon, MD has disclosed the following relevant financial relationships:
| Consultant: | Abbott, Amgen, Centocor, Galderma |
| Investigator: | Abbott, Centocor |
Dr. Gordon discusses the unlabeled or investigational use of a commercial product.
Jeffrey J. Crowley, MD has disclosed the following relevant financial relationships:
| Consultant: | Abbott, Genentech |
| Principal Investigator: | Abbott, Amgen, Genentech |
| Speaker: | Abbott, Amgen, Genentech |
Dr. Crowley discusses the unlabeled or investigational use of a commercial product.
Curatio CME Institute
Shari Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.
Derek Warnick, CME Director, has disclosed no relevant financial relationships.
EduPro Resources LLC
Dorothy Caputo, MA, APRN, BC-ADM, CDE, Operating Manager, has disclosed no relevant financial relationships.
Disclaimer
The information presented in this activity is for continuing medical education and continuing nursing education purposes only and is not meant to substitute for the independent medical judgment of a physician or nurse regarding diagnosis and treatment of a specific patient’s medical condition.
Accreditation refers to educational content only and does not imply EduPro, ANCC, NJSNA, or CBRN endorsement of any product.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute, EduPro Resources, and Centocor do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute, EduPro Resources, or Centocor. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Privacy Policy
Curatio CME Institute (Curatio) collects the information provided by the user. The information is used to notify users about upcoming programs and educational information that may be of interest to our users. The information is not shared for commercial purposes, unless prior permission has been granted by the user.
Curatio may collect standard Web traffic data such as the time and date of visit. Curatio uses this information to administer its Web site. Browsing activity is recorded to form aggregate and anonymous demographic information, which is used as described above. Curatio does not sell or offer to sell any user data, including registration and billing information, to any third parties for commercial purposes. Curatio does, when required, provide the minimum subset of information to third parties that are responsible for accreditation and issuance of certification of CME/CE tests submitted. By participating in the Web-based activity, you agree that Curatio has full permission to provide this minimum subset of information to the third parties as required by law.
For CME/CNE questions, please contact cmeinfo@curatiocme.com or call (610) 363-1619 ext. 113. If you experience technical difficulties, please contact helpdesk@axis-healthcare.com.